What is the appropriate management of a 15 kg child presenting with diabetic ketoacidosis?

Management of a 15 kg Child in DKA

Initiate immediate isotonic fluid resuscitation with 10-20 mL/kg (150-300 mL) of 0.9% normal saline over 20-30 minutes, followed by insulin infusion at 0.1 units/kg/hour (1.5 units/hour) starting 1-2 hours after fluid resuscitation begins, with careful potassium monitoring and replacement. 1, 2

Initial Fluid Resuscitation

The most critical first step is isotonic fluid bolus to restore perfusion and begin correcting dehydration:

• Give 10-20 mL/kg of 0.9% normal saline (150-300 mL for this 15 kg child) over the first 20-30 minutes 1, 2
• Recent evidence demonstrates that early isotonic fluid therapy does not increase cerebral edema risk and may improve outcomes 1
• This represents a shift from older fluid-restricting protocols that have not reduced cerebral injury rates 1

Subsequent Fluid Management

After initial resuscitation:

• Calculate remaining fluid deficit assuming 5-10% dehydration (750-1500 mL for 15 kg child)
• Replace deficit over 36-48 hours using 0.45% saline 1, 3
• Add maintenance fluids to deficit replacement
• For a 15 kg child: maintenance = approximately 50 mL/hour (using 100 mL/kg/day for first 10 kg + 50 mL/kg/day for next 5 kg)

Common pitfall: Avoid overly aggressive fluid administration beyond initial bolus, as this historically raised concerns about cerebral edema, though newer evidence suggests isotonic fluids are safer than previously thought 1.

Insulin Therapy

Critical timing: Start insulin 1-2 hours AFTER beginning fluid resuscitation, not simultaneously 2:

• Continuous IV insulin infusion at 0.1 units/kg/hour = 1.5 units/hour for this 15 kg child 4, 2, 3
• Do NOT give initial insulin bolus in pediatric DKA
• Maintain this rate until acidosis resolves (pH >7.3, bicarbonate >15 mEq/L, anion gap normalizes)
• When glucose falls below 250 mg/dL (13.9 mmol/L), add 10% dextrose to IV fluids but continue insulin at 0.1 units/kg/hour to clear ketones 4, 5

Important caveat: The guideline to reduce insulin to 0.05 units/kg/hour when glucose <250 mg/dL has shown poor real-world adoption and no clear benefit in reducing hypoglycemia 5. Maintaining 0.1 units/kg/hour while adding dextrose is the safer approach.

Potassium Management

This is life-threatening if missed:

• Do NOT start insulin until potassium >3.3 mEq/L and urine output is established
• Hypokalaemia occurs in ~50% of DKA cases during treatment and severe hypokalaemia (<2.5 mEq/L) increases mortality 4
• Add potassium to IV fluids early: typically 20-40 mEq/L once levels are adequate and patient is urinating
• Check potassium every 2-4 hours initially

Monitoring Requirements

Hourly for first 4-6 hours, then every 2-4 hours:

• Blood glucose (hourly until stable)
• Electrolytes including potassium (every 2-4 hours)
• Venous pH and bicarbonate (every 2-4 hours until resolved)
• Neurological status (hourly - watch for cerebral edema signs: headache, altered mental status, bradycardia, hypertension)

Cerebral Edema Recognition

Most common cause of DKA mortality in children 2, 3:

Warning signs:

• Headache, altered mental status
• Recurrent vomiting after initial improvement
• Bradycardia with hypertension
• Decreased oxygen saturation

Immediate treatment if suspected:

• Mannitol 0.5-1 g/kg IV over 10-20 minutes OR
• 3% hypertonic saline 2.5-5 mL/kg over 10-30 minutes 2

Contraindications

Do NOT give bicarbonate - it is contraindicated in pediatric DKA as it may paradoxically worsen cerebral edema risk 2, 3

Transition to Subcutaneous Insulin

Once DKA resolves (pH >7.3, bicarbonate >15 mEq/L, anion gap closed, patient tolerating oral intake):

• Start subcutaneous insulin and continue IV insulin for 1-2 hours overlap
• Initiate metformin if this is type 2 diabetes 6
• Calculate total daily insulin dose from average hourly IV rate over last 12 hours × 24

Special Consideration for Type Determination

In a child with obesity presenting in DKA, diabetes type may be uncertain initially 6. Treat the DKA first with the protocol above regardless of suspected type, then adjust long-term management once metabolic compensation is achieved and autoantibody results are available 6.